. All the strains were susceptible to vancomycin and teicoplanin. Ciprofloxacin and ofloxacin were very active, with MICs for 90% of isolates equal to or less than 1 ,ug/ml. Norfloxacin was less active than the other quinolones but is potentially useful for urinary tract infections (MIC for 90% of isolates, 8 ,ug/ml). Only a few strains were susceptible to erythromycin, josamycin, ampicillin, and gentamicin, but there was no evident relationship between the susceptibility or resistance data for these strains and one or more drugs, with the exception of a cross-resistance between erythromycin and josamycin, the former being weight-by-weight more active than the latter.
There were no significant differences in antimicrobial susceptibility between clinical and colonizing isolates. The existence of previous antimicrobial chemotherapy did not influence susceptibility or resistance; furthermore, there were no data to suggest differences in antimicrobial susceptibility among skin isolates in relation to the composition of the selective medium used.
The antimicrobial susceptibility of clinical isolates of Corynebacterium group D2 was recently described (4). The most active antimicrobial agents were vancomycin and norfloxacin. Novobiocin and rifampin were also active against many isolates (4) . In the present study, we showed that some new drugs, such as ciprofloxacin, ofloxacin, and teicoplanin, are also very active against Corynebacterium group D2. These three drugs may be satisfactory alternatives for the treatment of infections caused by this microorganism, not only when it produces urinary tract infections but also in systemic infections.
There were no significant differences in antimicrobial susceptibility between clinical and colonizing isolates. Previous antimicrobial chemotherapy seems not to have affected antimicrobial susceptibility of colonizing isolates. Nevertheless, all these strains were isolated from skin of hospitalized patients, and we were unable to evaluate the pressure of current antimicrobial agents, although we did not detect any horizontal transmission of Corynebacterium group D2 among inpatients. The selective medium used to isolate skin strains seems not to have affected the antimicrobial susceptibility pattern shown by colonizing isolates.
There were no significant differences in the antimicrobial susceptibility of skin isolates when different selective media were used, perhaps because most strains were beta-lactam and aminoglycoside resistant.
Human skin flora is very rich in coryneform bacteria, most of them susceptible to many antimicrobial agents (1) . Corynebacterium groups D2 and JK are, however, part of the ANTIMICROB. AGENTS CHEMOTHER. b MICs for all isolates, except three (MIC, <64 ,ug/ml), were equal to or higher than 512 p.g/ml.
skin flora and are resistant to many drugs. It has been suggested that Corynebacterium group JK is a susceptible skin corynebacterium which, for different reasons, develops resistance to many antimicrobial agents (2) . If this hypothesis was correct, it could also be speculated that Corynebacterium group D2 might'also be a highly resistant variant of another normal skin coryneform bacterium. Nevertheless, we isolated Corynebacterium group D2 from healthy skin of patients who were not receiving antimicrobial agents but who were hospitalized. We have not been able to isolate this microorganism from skin of 100 healthy individuals or hospital staff (unpublished data). Our results show that the antimicrobial susceptibility of Corynebacterium group D2 isolated from skin of hospitalized patients is quite similar to that of clinical isolates and that there are no differences in susceptibility in relation to previous antimicrobial chemotherapy.
However, we do not have enough data to speculate on the probable origin of Corynebacterium group D2, which may be an individualized species or a multiresistant variant of another skin coryneform bacterium.
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